Tools

LEADER 03692nam a2200577 i 4500

001 on1395405055;

003 OCoLC;

005 20231106090930.0;

006 m o d f ;

007 cr b|||||a||||;

008 230828s2023 dcu ob f000 0 eng c;

024 8 a| 51-563q| (GPO jacket number);

035 a| (Sirsi) o1395405055;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:118-2;

088 a| Serial no. 118-2 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| Lives worth living :b| addressing the fentanyl crisis, protecting critical lifelines, and combating discrimination against those with disabilities : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, February 1, 2023.;

246 3 a| Addressing the fentanyl crisis, protecting critical lifelines, and combating discrimination against those with disabilities;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2023.;

300 a| 1 online resource (vi, 316 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| Associated bill citation(s): H.R. 467; H.R. 485; H.R. 498.;

500 a| "Serial no. 118-2.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Kemp Chester, Senior Advisor, Office of National Drug Control Policy; Neeraj Gandotra, M.D., Chief Medical Officer, Substance Abuse and Mental Health Services Administration, Department of Health and Human Services; John DeLena, Associate Administrator, Drug Enforcement Administration, Department of Justice; Kandi Pickard, President and Chief Executive Officer, National Down Syndrome Society; Frederick Isasi, Executive Director, Families USA; Molly A. Cain, Parent Advocate; Stephen Loyd, M.D., Chief Medical Officer, Cedar Recovery; Timothy W. Westlake, M.D., Emergency Medicine Physician.;

518 a| Date of hearing: 2023-02-01.;

588 a| Description based on online resource, PDF version; title from title page (GovInfo, viewed Aug, 28, 2023).;

650 0 a| Opioid abusez| United Statesx| Prevention.=| ^A1017318;

650 0 a| Drug addictionx| Treatmentz| United States.=| ^A651793;

650 0 a| Drugsx| Law and legislationz| United States.=| ^A639;

610 20 a| U.S. Customs and Border Protectionv| Rules and practice.=| ^A577617;

650 7 a| Health.2| cgpa;

655 7 a| Legislative hearings.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2013025047;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce.t| Lives worth livingw| (OCoLC)1395405183;

856 40 u| https://purl.fdlp.gov/GPO/gpo2159257| 0;

922 a| BIBCONEWb| 20230828;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6235123;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6235123-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 9/15/2023x| EDOCUMENTz| JERESOURCE;

Lives worth living : addressing the fentanyl crisis, protecting critical lifelines, and combating discrimination against those with disabilities : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighteenth Congress, first session, February 1, 2023.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2023.
Description	1 online resource (vi, 316 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo215925
Subjects	U.S. Customs and Border Protection--Rules and practice. Fentanyl--Overdose. --United States. --Prevention. Opioid abuse--United States. --Prevention. Drug addiction--Treatment. --United States. Opioids--Overdose. --United States. --Prevention. Drugs--Law and legislation. --United States.

Variant title	Addressing the fentanyl crisis, protecting critical lifelines, and combating discrimination against those with disabilities
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	Associated bill citation(s): H.R. 467; H.R. 485; H.R. 498.
General note	"Serial no. 118-2."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Kemp Chester, Senior Advisor, Office of National Drug Control Policy; Neeraj Gandotra, M.D., Chief Medical Officer, Substance Abuse and Mental Health Services Administration, Department of Health and Human Services; John DeLena, Associate Administrator, Drug Enforcement Administration, Department of Justice; Kandi Pickard, President and Chief Executive Officer, National Down Syndrome Society; Frederick Isasi, Executive Director, Families USA; Molly A. Cain, Parent Advocate; Stephen Loyd, M.D., Chief Medical Officer, Cedar Recovery; Timothy W. Westlake, M.D., Emergency Medicine Physician.
Date/time/place of a event note	Date of hearing: 2023-02-01.
Source of description	Description based on online resource, PDF version; title from title page (GovInfo, viewed Aug, 28, 2023).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Lives worth living
Genre/form	Legislative hearings.
Standard identifier#	51-563 (GPO jacket number)
Technical rpt number	Serial no. 118-2 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:118-2

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability